Jonathan Violin - 02 Jun 2023 Form 4 Insider Report for Astria Therapeutics, Inc. (ATXS)

Role
Director
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Jonathan Violin
Issuer symbol
ATXS
Transactions as of
02 Jun 2023
Net transactions value
$0
Form type
4
Filing time
06 Jun 2023, 08:06:13 UTC
Previous filing
07 Feb 2023
Next filing
13 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATXS Stock Option (Right to Buy) Award $0 +14,100 $0.000000 14,100 02 Jun 2023 Common Stock 14,100 $11.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 2, 2023 and will vest in its entirety on the one-year anniversary of the grant date, subject to the director's continued service.